Literature DB >> 8305164

Renin, angiotensinogen, and kallikrein gene expression in two-kidney Goldblatt hypertensive rats.

S S el-Dahr1, S Dipp, S Guan, L G Navar.   

Abstract

An imbalance in the activity of the vasopressor renin-angiotensin and vasodepressor kallikrein-kinin systems may play an important role in the pathogenesis of hypertension after unilateral renal artery constriction. To test this hypothesis, we examined the expression of the renin, angiotensinogen (Ao), and tissue kallikrein genes 7 and 25 days after placement of a 0.25-mm clip on the left renal artery of rats. One week after clipping, renin mRNA levels were 4.6-fold higher in the clipped and 50% lower in the nonclipped kidneys compared with kidneys from sham-operated rats. At 25 days, renin mRNA levels in the clipped kidneys were not different from sham kidneys, but were suppressed to almost undetectable levels in the nonclipped kidneys. Steady-state Ao mRNA levels in the clipped kidneys were not different from those of nonclipped or sham kidneys at either 7 or 25 days. However, at 25 days, Ao mRNA levels were lower in the liver (70%), left ventricle (55%), and aorta (45%) of clipped than sham-operated rats. The expression of the renal kallikrein gene was unchanged at 7 days and was suppressed by 50% at 25 days. These results are consistent with the notion that activation of the intrarenal renin-angiotensin system occurs during the initial phase of the two-kidney, one-clip hypertension model. The renal kallikrein gene, in marked contrast to renin, becomes downregulated in the chronic phase. The differential regulation of renin-angiotensin and kallikrein genes may be an important pathogenetic factor in renovascular hypertension.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8305164     DOI: 10.1093/ajh/6.11.914

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  10 in total

1.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

2.  Angiotensin II type 1 receptor-mediated augmentation of urinary excretion of endogenous angiotensin II in Val5-angiotensin II-infused rats.

Authors:  Weijian Shao; Dale M Seth; L Gabriel Navar
Journal:  Hypertension       Date:  2010-07-12       Impact factor: 10.190

3.  Role of cytochrome P-450 metabolites in the regulation of renal function and blood pressure in 2-kidney 1-clip hypertensive rats.

Authors:  Alexandra Sporková; Libor Kopkan; Sárka Varcabová; Zuzana Husková; Sung Hee Hwang; Bruce D Hammock; John D Imig; Herbert J Kramer; Ludek Cervenka
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-03-16       Impact factor: 3.619

4.  Effect of renal perfusion pressure on renal function, renin release and renin and angiotensinogen gene expression in rats.

Authors:  S M Moosavi; E J Johns
Journal:  J Physiol       Date:  1999-10-01       Impact factor: 5.182

5.  Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats.

Authors:  Agnieszka Walkowska; Petra Skaroupková; Zuzana Husková; Zdenka Vanourková; Vera Certíková Chábová; Vladimír Tesar; Herbert J Kramer; John R Falck; John D Imig; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Ludek Cervenka
Journal:  J Hypertens       Date:  2010-03       Impact factor: 4.844

6.  Interlobular Arteries From 2-Kidney, 1-Clip Goldblatt Hypertensive Rats' Exhibit-Impaired Vasodilator Response to Epoxyeicosatrienoic Acids.

Authors:  Alexandra Sporková; Rami N Reddy; John R Falck; John D Imig; Libor Kopkan; Janusz Sadowski; Luděk Červenka
Journal:  Am J Med Sci       Date:  2016-02-23       Impact factor: 2.378

Review 7.  Development biology of the renal kallikrein-kinin system.

Authors:  S S el-Dahr
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

8.  Increased susceptibility to hypertensive renal disease in streptozotocin-treated diabetic rats is not modulated by salt intake.

Authors:  C A Sima; M P Koeners; J A Joles; B Braam; A B Magil; W A Cupples
Journal:  Diabetologia       Date:  2012-05-06       Impact factor: 10.122

9.  Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats.

Authors:  Weijian Shao; Dale M Seth; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-25

10.  Soluble epoxide hydrolase inhibition exhibits antihypertensive actions independently of nitric oxide in mice with renovascular hypertension.

Authors:  Libor Kopkan; Zuzana Husková; Alexandra Sporková; Šárka Varcabová; Zuzana Honetschlägerová; Sung Hee Hwang; Hsing-Ju Tsai; Bruce D Hammock; John D Imig; Herbert J Kramer; Marcela Bürgelová; Alžběta Vojtíšková; Petr Kujal; Zdenka Vernerová; Luděk Červenka
Journal:  Kidney Blood Press Res       Date:  2012-08-29       Impact factor: 2.687

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.